Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "J05" (192)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Aciclovir (J05AB01) 8 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Zovirax 200 mg
-
T
25 Tablet(s)
12.74
30.15
10 %
Filmtabletten (suspendierbar): Aciclovirum 200 mg
GlaxoSmithKline AG
A / SL / SO
FB
G
L
IP
CI
Acyclovir-Mepha 200
25 Tablet(s)
10.83
28.20
10 %
Tablets: Aciclovirum 200 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Acyclovir-Mepha 400
‐
I
30 Tablet(s)
21.31
39.60
10 %
Tablets: Aciclovirum 400 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Acyclovir-Mepha 400
‐
I
70 Tablet(s)
47.58
68.15
10 %
Tablets: Aciclovirum 400 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Acyclovir-Mepha 800
35 Tablet(s)
42.35
62.45
10 %
Tablets: Aciclovirum 800 mg
Mepha Pharma AG
●
A / SL / SG
FB
G
L
IP
CI
Zovirax
100 ml
26.18
44.90
10 %
Suspension: Aciclovirum 400mg / 5ml
GlaxoSmithKline AG
A / SL
FB
G
IP
Zovirax i.v.
5 ampoule(s)
k.A.
Lyophilisate: Aciclovirum 250 mg
GlaxoSmithKline AG
A
FB
G
IP
Aciclovir Labatec
5 Durchstechflasche(n)
k.A.
Dry substance: Aciclovirum 250 mg
Labatec Pharma SA
A
FB
G
Ganciclovir (J05AB06) 3 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Cymevene
ampoule(s)
47.75
68.35
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Ganciclovirum 500 mg
Cheplapharm Schweiz
GmbH
A / SL
FB
G
IP
CI
Cymevene 250 mg
84 Capsule(s)
k.A.
Capsules: Ganciclovirum 250 mg
Roche Pharma
(Schweiz) AG
A
FB
G
IP
CI
Cymevene 500 mg
90 Capsule(s)
1570.45
k.A.
Capsules: Ganciclovirum 500 mg
Roche Pharma
(Schweiz) AG
A
FB
G
Famciclovir (J05AB09) 5 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Famvir 125 mg
10 Tablet(s)
21.06
39.30
10 %
Coated tablets: Famciclovirum 125 mg
Atnahs Pharma
Switzerland AG
A / SL
FB
G
IP
CI
Famvir 250 mg
-
T
15 Tablet(s)
58.28
79.80
10 %
Coated tablets: Famciclovirum 250 mg
Atnahs Pharma
Switzerland AG
A / SL
FB
G
IP
CI
Famvir 500 mg
14 Tablet(s)
99.03
124.10
10 %
Coated tablets: Famciclovirum 500 mg
Atnahs Pharma
Switzerland AG
A / SL
FB
G
IP
CI
Famvir 500 mg
21 Tablet(s)
135.30
163.55
10 %
Coated tablets: Famciclovirum 500 mg
Atnahs Pharma
Switzerland AG
A / SL
FB
G
IP
CI
Famvir 500 mg
30 Tablet(s)
202.18
236.30
10 %
Coated tablets: Famciclovirum 500 mg
Atnahs Pharma
Switzerland AG
A / SL
FB
G
Cidofovir (J05AB12) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
Sidovis
k.A.
Concentrate for infusion: Cidofovirum 75 mg/ml
Ideogen AG
A
FB
G
IP
Vistide
ampoule(s)
980.30
1136.65
k.A.
Concentrate for infusion: Cidofovirum 375mg / 5ml
Gilead Sciences
Switzerland Sàrl
A
FB
G
Valganciclovir (J05AB14) 3 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Valcyte
60 Tablet(s)
1159.41
1270.85
10 %
Coated tablets: Valganciclovirum 450 mg
Cheplapharm Schweiz
GmbH
A / SL / SO
FB
G
IP
CI
Valganciclovir Sandoz 450 mg
60 Tablet(s)
1054.01
1162.70
10 %
Coated tablets: Valganciclovirum 450 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Valganciclovir-Mepha 450
60 Tablet(s)
1054.01
1162.70
10 %
Coated tablets: Valganciclovirum 450 mg
Mepha Pharma AG
A / SL / SG
FB
G
Brivudine (J05AB15) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Brivex
7 Tablet(s)
60.90
82.65
10 %
Tablets: Brivudinum 125 mg
A. Menarini GmbH
A / SL
FB
G
Foscarnet (J05AD01) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
Foscarnet Ideogen 24
mg/ml
k.A.
Infusion solution: Foscarnetum Natricum Hexahydricum 24 mg/ml
Ideogen AG
A
FB
G
IP
Foscavir
250 ml
k.A.
Infusion solution: Foscarnetum Natricum Hexahydricum 24 mg/ml
Curatis AG
A
FB
G
Atazanavir (J05AE08) 3 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Atazanavir-Mepha 200mg
60
353.72
401.10
10 %
Capsules: Atazanavirum 200 mg
Mepha Pharma AG
●
A / SL / SG
FB
G
IP
CI
Atazanavir-Mepha 300mg
30
353.72
401.10
10 %
Capsules: Atazanavirum 300 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Atazanavir-Mepha 150mg
60
k.A.
Capsules: Atazanavirum 150 mg
Mepha Pharma AG
A
FB
G
Darunavir (J05AE10) 12 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Prezista 600 mg
60 Tablet(s)
579.03
631.20
10 %
Coated tablets: Darunavirum 600 mg
Janssen-Cilag AG
A / SL / SO
FB
G
IP
CI
Prezista 800 mg
30 Tablet(s)
386.02
426.30
20 %
Coated tablets: Darunavirum 800 mg
Janssen-Cilag AG
A / SL / SO
FB
G
IP
CI
Darunavir Sandoz 400 mg
60
234.92
271.25
10 %
Coated tablets: Darunavirum 400 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Darunavir Sandoz 600 mg
60
352.40
398.70
10 %
Coated tablets: Darunavirum 600 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Darunavir Sandoz 800 mg
30
234.92
271.25
10 %
Coated tablets: Darunavirum 800 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Darunavir Viatris 400 mg
60
213.57
249.35
10 %
Tablets: Darunavirum 400 mg
Viatris Pharma GmbH
●
A / SL / SG
FB
G
IP
CI
Darunavir Viatris 600 mg
60
320.37
365.80
10 %
Tablets: Darunavirum 600 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
IP
CI
Darunavir Viatris 800 mg
30
213.57
249.35
10 %
Tablets: Darunavirum 800 mg
Viatris Pharma GmbH
A / SL / SG
FB
G
IP
CI
Prezista 100 mg/ml
Flasche(n)
k.A.
Suspension (oral): Darunavirum 100 mg/ml
Janssen-Cilag AG
A
FB
G
IP
CI
Darunavir Sandoz 400 mg
60
k.A.
Coated tablets: Darunavirum 400 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Darunavir Sandoz 600 mg
60
k.A.
Coated tablets: Darunavirum 600 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Darunavir Sandoz 800 mg
30
k.A.
Coated tablets: Darunavirum 800 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (J05AF) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Vemlidy
30
449.12
504.85
10 %
Coated tablets: Tenofovirum Alafenamidum 25 mg
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
Lamivudine (J05AF05) 8 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Lamivudin-Mepha 150
60
138.32
166.85
10 %
Coated tablets: Lamivudinum 150 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Lamivudin-Mepha 300
30
138.32
166.85
10 %
Coated tablets: Lamivudinum 300 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Zeffix
-
T
28 Tablet(s)
59.42
81.05
10 %
Coated tablets: Lamivudinum 100 mg
GlaxoSmithKline AG
A / SL
FB
G
L
IP
CI
Zeffix
-
T
84 Tablet(s)
153.23
183.05
10 %
Coated tablets: Lamivudinum 100 mg
GlaxoSmithKline AG
A / SL
FB
G
L
IP
CI
Zeffix
240 ml
27.75
46.60
10 %
Solution (oral): Lamivudinum 5 mg/ml
GlaxoSmithKline AG
A / SL
FB
G
IP
CI
3TC 150 mg
60 Tablet(s)
162.73
191.90
10 %
Coated tablets: Lamivudinum 150 mg
ViiV Healthcare GmbH
A / SO
FB
G
IP
CI
3TC 300 mg
30 Tablet(s)
162.73
191.90
10 %
Coated tablets: Lamivudinum 300 mg
ViiV Healthcare GmbH
A / SO
FB
G
IP
CI
3TC
240 ml
50.28
71.10
10 %
Lösung oral: Lamivudinum 10 mg/ml
ViiV Healthcare GmbH
A
FB
G
Abacavir (J05AF06) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Ziagen
-
T
60 Tablet(s)
199.02
232.85
10 %
Coated tablets: Abacavirum 300 mg
ViiV Healthcare GmbH
A / SL
FB
G
IP
CI
Ziagen
240 ml
56.91
78.30
10 %
Solution (oral): Abacavirum 20 mg/ml
ViiV Healthcare GmbH
A / SL
FB
G
Emtricitabine (J05AF09) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
SIP
IP
CI
Emtriva
30 Capsule(s)
181.54
213.85
10 %
Capsules: Emtricitabinum 200 mg
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
Entecavir (J05AF10) 15 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Baraclude 0.5 mg
30 Tablet(s)
368.09
413.35
10 %
Coated tablets: Entecavirum
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
IP
CI
Baraclude 1 mg
30 Tablet(s)
464.79
517.60
10 %
Coated tablets: Entecavirum 1 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
IP
CI
Entecavir Sandoz 0.5 mg
30 + 30 + 30 + 30 + 30
312.88
356.70
10 %
Coated tablets: Entecavirum
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
L
IP
CI
Entecavir Sandoz 1 mg
30 + 30 + 30 + 30 + 30
395.06
446.05
10 %
Coated tablets: Entecavirum 1 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Entecavir-Mepha 0.5mg
30
312.88
356.70
10 %
Coated tablets: Entecavirum
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Entecavir-Mepha 1.0mg
30
395.06
446.05
10 %
Coated tablets: Entecavirum 1 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Baraclude 0.05 mg/mL
210 ml
k.A.
Solution (oral): Entecavirum
Bristol-Myers Squibb SA
A
FB
G
IP
CI
Baraclude 0.5 mg
30
312.88
356.70
10 %
Coated tablets: Entecavirum
APS-Arzneimittel-
Parallelimport-
Service AG
A / SL / SO
FB
G
L
IP
CI
Baraclude 1 mg
30
434.56
486.60
10 %
Coated tablets: Entecavirum 1 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A / SL / SO
FB
G
IP
CI
Baraclude 0.5 mg
30
k.A.
Coated tablets: Entecavirum
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
CI
Baraclude 0.5 mg
30
k.A.
Coated tablets: Entecavirum
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
Baraclude 1 mg
30
k.A.
Coated tablets: Entecavirum 1 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
Baraclude 1 mg
30
k.A.
Coated tablets: Entecavirum 1 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
CI
Entecavir Sandoz 0.5 mg
30
k.A.
Coated tablets: Entecavirum
Sandoz
Pharmaceuticals AG
A
FB
G
IP
CI
Entecavir Sandoz 1 mg
30
k.A.
Coated tablets: Entecavirum 1 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Efavirenz (J05AG03) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Efavirenz-Mepha 600 mg
30 Tablet(s)
211.41
246.35
10 %
Coated tablets: Efavirenzum 600 mg
Mepha Pharma AG
A / SL / SG
FB
G
Etravirine (J05AG04) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
SIP
IP
CI
Intelence 200 mg
60 Tablet(s)
335.75
381.55
10 %
Tablets: Etravirinum 200 mg
Janssen-Cilag AG
A / SL
FB
G
Doravirine (J05AG06) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
Pifeltro
30
354.43
401.90
10 %
Coated tablets: Doravirinum 100 mg
MSD Merck Sharp &
Dohme AG
A / SL
FB
G
Cabotegravir (J05AJ04) 3 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
Vocabria 30 mg
30
547.13
611.45
10 %
Coated tablets: Cabotegravirum 30 mg
ViiV Healthcare GmbH
A / SL
FB
G
L
IP
Vocabria 600 mg / 3 ml
1140.05
1256.30
10 %
Depot-Injektionssuspension: Cabotegravirum 600mg / 3ml
ViiV Healthcare GmbH
A / SL
FB
G
IP
Vocabria 400 mg / 2 ml
k.A.
Depot-Injektionssuspension: Cabotegravirum 400mg / 2ml
ViiV Healthcare GmbH
A
FB
G
Glecaprevir and Pibrentasvir (J05AP57) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
PP
Maviret Filmtabletten
84
13148.57
13798.25
10 %
2 Active Agents
AbbVie AG
A / SL
FB
G
Lamivudine and Abacavir (J05AR02) 6 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Kivexa
30 Tablet(s)
273.20
311.00
10 %
Coated tablets: 2 Active Agents
ViiV Healthcare GmbH
A / SL / SO
FB
G
IP
CI
Abacavir-Lamivudin-Mepha 600
mg/300 mg
30
232.22
268.95
10 %
Coated tablets: 2 Active Agents
Mepha Pharma AG
A / SG
FB
G
IP
CI
Abacavir Lamivudin Sandoz
30
232.22
268.95
10 %
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
A / SG
FB
G
IP
CI
Kivexa 600 mg / 300 mg
30
k.A.
Coated tablets: 2 Active Agents
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
CI
Kivexa 600 mg / 300 mg
30
k.A.
Coated tablets: 2 Active Agents
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
CI
Kivexa 600mg/300 mg
30
k.A.
Coated tablets: 2 Active Agents
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
Emtricitabine, Tenofovir Disoproxil and Efavirenz (J05AR06) 4 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Efavirenz-Emtricitabin-
Tenofovir-Mepha 600 mg, 200 mg
30
526.02
588.50
10 %
mg: 3 Active Agents
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Efavirenz/Emtricitabin/Tenofovir
Viatris
30
526.02
588.50
k.A.
Mylan: 3 Active Agents
Viatris Pharma GmbH
A
FB
G
IP
CI
Efavirenz/Emtricitabin/Tenofovir
Viatris
30
526.02
588.50
k.A.
Mylan: 3 Active Agents
Viatris Pharma GmbH
A
FB
G
IP
CI
Efavirenz-Emtricitabin-
Tenofovir-Mepha 600 mg, 200 mg
3 x 30
k.A.
mg: 3 Active Agents
Mepha Pharma AG
A
FB
G
Emtricitabine, Tenofovir Disoproxil and Rilpivirine (J05AR08) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
PP
Eviplera
30 Tablet(s)
760.30
843.30
10 %
Coated tablets: 3 Active Agents
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
Emtricitabine and Tenofovir Alafenamide (J05AR17) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Descovy 200/10 mg
30
612.80
682.85
10 %
Coated tablets: 2 Active Agents
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
IP
CI
Descovy 200/25 mg
30
612.80
682.85
10 %
Coated tablets: 2 Active Agents
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
Emtricitabine, Tenofovir Alafenamide, Elvitegravir and Cobicistat (J05AR18) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
PP
Genvoya
150mg/150mg/200mg/10mg
30
954.12
1054.10
10 %
Coated tablets: 4 Active Agents
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
Emtricitabine, Tenofovir Alafenamide and Rilpivirine (J05AR19) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Odefsey 200/25/25 mg
30
708.08
786.50
10 %
Coated tablets: 3 Active Agents
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
Emtricitabine, Tenofovir Alafenamide and Bictegravir (J05AR20) 2 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Biktarvy
30
1005.60
1110.05
10 %
Coated tablets: 3 Active Agents
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
IP
CI
Biktarvy
30
1005.60
1110.05
10 %
Coated tablets: 3 Active Agents
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
Dolutegravir and Rilpivirine (J05AR21) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Juluca 50 mg
30
855.65
947.00
10 %
Coated tablets: 2 Active Agents
ViiV Healthcare GmbH
A / SL
FB
G
Emtricitabine, Tenofovir Alafenamide, Darunavir and Cobicistat (J05AR22) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Symtuza
30
916.64
1013.30
10 %
Coated tablets: 4 Active Agents
Janssen-Cilag AG
A / SL
FB
G
Lamivudine and Dolutegravir (J05AR25) 2 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Dovato
30
700.45
778.20
10 %
Coated tablets: 2 Active Agents
ViiV Healthcare GmbH
A / SL
FB
G
IP
CI
Dovato
30
700.45
778.20
10 %
Coated tablets: 2 Active Agents
ViiV Healthcare GmbH
A / SL
FB
G
Baloxavir Marboxil (J05AX25) 6 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Xofluza 40 mg
k.A.
Coated tablets: Baloxavirum Marboxilum 40 mg
Roche Pharma
(Schweiz) AG
B
FB
G
IP
CI
Xofluza 40 mg
2
k.A.
Coated tablets: Baloxavirum Marboxilum 40 mg
Roche Pharma
(Schweiz) AG
B
FB
G
IP
CI
Xofluza 80 mg
k.A.
Coated tablets: Baloxavirum Marboxilum 80 mg
Roche Pharma
(Schweiz) AG
B
FB
G
IP
CI
Xofluza 2 mg / ml
k.A.
Granulat zur Herstellung einer Suspension zum Einnehmen: Baloxavirum Marboxilum 40 mg
Roche Pharma
(Schweiz) AG
B
FB
G
IP
CI
Xofluza 20 mg
2
k.A.
Coated tablets: Baloxavirum Marboxilum 20 mg
Roche Pharma
(Schweiz) AG
B
FB
G
IP
CI
Xofluza 20 mg
4
k.A.
Coated tablets: Baloxavirum Marboxilum 20 mg
Roche Pharma
(Schweiz) AG
B
FB
G
Bulevirtide (J05AX28) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
Hepcludex 2 mg
30
5449.37
5898.85
10 %
Dry substance: Bulevirtidum 2 mg
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
Fostemsavir (J05AX29) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Rukobia 600 mg
60
k.A.
Delayed release tablets: Fostemsavirum 600 mg
ViiV Healthcare GmbH
A
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
